Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.
暂无分享,去创建一个
Richard D Moore | J. Robins | M. Hernán | R. Haubrich | J. Sterne | M. Petersen | A. d’Arminio Monforte | M. Egger | R. Hogg | C. Sabin | S. Boswell | A. Phillips | P. Reiss | M. Mugavero | M. Saag | F. Dabis | A. Antinori | D. Costagliola | M. May | A. Justice | J. Guest | A. Monforte | S. Deeks | L. Meyer | G. Touloumi | E. Geng | C. Stephan | A. van Sighem | J. Eron | J. Rybniker | S. Pérez-Hoyos | M. Kitahata | B. Rodriguez | H. Bucher | B. Shepherd | S. Moreno | A. Sighem | A. Cozzi-Lepri | J. Casabona | S. Abgrall | S. Napravnik | H. Samji | G. Vourli | J. Del Amo | J. Amo | R. Teira | R. Logan | J. Tate | Stephen E. Van Rompaey | Suzanne M Ingle | S. Ingle | I. Jarrín | M. Vandenhende | S. Jose | R. Seng | L. E. Cain | M. John Gill | C. Campbell | Ashley D. Olson | M. Gill | A. Olson | Matthias Egger | S. V. Van Rompaey | S. V. Rompaey | M. Petersen | S. Rompaey | Richard D. Moore
[1] Stacey A. Kenfield,et al. Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study. , 2015, European journal of cancer.
[2] Miguel A Hernán,et al. The hazards of hazard ratios. , 2010, Epidemiology.
[3] Mark J van der Laan,et al. Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification , 2008, AIDS.
[4] Richard D Moore,et al. Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. , 2008, International journal of epidemiology.
[5] James M Robins,et al. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals , 2010, AIDS.
[6] M. Robins James,et al. Estimation of the causal effects of time-varying exposures , 2008 .
[7] John W. Ward,et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[8] Douglas D. Richman,et al. Antiretroviral Treatment of Adult HIV Infection , 2008 .
[9] M. Hernán,et al. Evaluation of the Duplication of Staging CT Scans for Localized Colon Cancer in a Medicare Population , 2014, Medical care.
[10] James M. Robins,et al. The International Journal of Biostatistics CAUSAL INFERENCE When to Start Treatment ? A Systematic Approach to the Comparison of Dynamic Regimes Using Observational Data , 2011 .
[11] J. Robins. A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect , 1986 .
[12] J.,et al. The New England Journal of Medicine , 2012 .
[13] James M. Robins,et al. Observational Studies Analyzed Like Randomized Experiments: An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease , 2008, Epidemiology.
[14] M. Hernán,et al. Comparative Effectiveness of Two Anemia Management Strategies for Complex Elderly Dialysis Patients , 2014, Medical care.
[15] C. Leen,et al. British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.) , 2014, HIV medicine.
[16] C. Leen,et al. British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015 , 2016, HIV medicine.
[17] Eoin Coakley,et al. Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Jonathan AC Sterne,et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies , 2002, The Lancet.
[19] James M. Robins,et al. Comparative Effectiveness of Dynamic Treatment Regimes: An Application of the Parametric G-Formula , 2011, Statistics in biosciences.
[20] Jennifer F Hoy,et al. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel. , 2014, JAMA.
[21] James M Robins,et al. The International Journal of Biostatistics CAUSAL INFERENCE Dynamic Regime Marginal Structural Mean Models for Estimation of Optimal Dynamic Treatment Regimes , Part II : Proofs of Results , 2011 .
[22] W. A. Thompson,et al. On the treatment of grouped observations in life studies. , 1977, Biometrics.
[23] M. J. van der Laan,et al. The International Journal of Biostatistics Causal Effect Models for Realistic Individualized Treatment and Intention to Treat Rules , 2011 .
[24] J. Robins,et al. The International Journal of Biostatistics CAUSAL INFERENCE Dynamic Regime Marginal Structural Mean Models for Estimation of Optimal Dynamic Treatment Regimes , Part I : Main Content , 2011 .
[25] R. Little,et al. The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.
[26] J. Robins,et al. Comparison of dynamic treatment regimes via inverse probability weighting. , 2006, Basic & clinical pharmacology & toxicology.
[27] Brent A. Johnson,et al. Modeling Clinical Endpoints as a Function of Time of Switch to Second‐Line ART with Incomplete Data on Switching Times , 2013, Biometrics.
[28] Uwe Siebert,et al. Effects of multiple interventions , 2004 .
[29] Roger Logan,et al. Observational data for comparative effectiveness research: An emulation of randomised trials of statins and primary prevention of coronary heart disease , 2013, Statistical methods in medical research.
[30] J. Sterne,et al. Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). , 2014, International journal of epidemiology.
[31] Stephen R Cole,et al. Constructing inverse probability weights for marginal structural models. , 2008, American journal of epidemiology.
[32] Brent A. Johnson,et al. Evaluating the Effect of Early Versus Late ARV Regimen Change if Failure on an Initial Regimen: Results From the AIDS Clinical Trials Group Study A5095 , 2012, Journal of the American Statistical Association.
[33] J. Robins,et al. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. , 2000, Epidemiology.
[34] Amalio Telenti,et al. Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel , 2010 .